Search
Selected Filters
Filter Results
Displaying 91–100 of 135 news results
-
Jul 22, 2020
Accepting grant applications for advancing retinal degeneration treatments toward human studies
-
Jun 16, 2020
Foundation Fighting Blindness to Host Virtual VISIONS 2020 Conference
The national conference will be held virtually on June 25-27, providing the latest in science and research, practical adapting and thriving, and an opportunity to connect with others who are visually impaired.
-
May 19, 2020
Inherited Retinal Disease Genetic Testing Webinar-Workshop for Eye Care Professionals
Hosted by the Foundation Fighting Blindness, Blueprint Genetics, and InformedDNA June 4, 2020, 12:00 p.m.–1:30 p.m. ET
-
May 15, 2020
Enhancements include streamlined data entry, improved site navigation, better accessibility for low-vision users, and efficient integration with mobile technology.
-
May 7, 2020
Foundation and Vision Partners Seek Biomedical Research Support from Congress during COVID-19 Crisis
Delays in Research Impacting Therapy Development
-
Apr 22, 2020
The inaugural credit-based event will include education on inherited retinal diseases, physician resources, and current clinical trials.
-
Apr 10, 2020
Why Science Is Closer Than You Think To Beating Blindness
Using high-tech, camera-equipped eyeglasses and a healthy pair of eyes with 20/20 vision located hundreds, maybe even thousands, of miles away, a blind New York attorney has help to navigate the city’s busy streets and broken sidewalks.
-
Mar 31, 2020
The Foundation Fighting Blindness is closely monitoring the COVID-19 situation and its impact on the IRD community.
-
Feb 14, 2020
People with disabilities are no different from anyone else. We all have strengths and challenges, and we all seek to be fully engaged in society. Treating blind people differently, either as incapable of conducting everyday tasks in life, or conversely, acting as though our ability to conduct even the most mundane chore is remarkable can be discouraging.
-
Feb 6, 2020
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.